SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NexStar Pharm(NXTR)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Steven Yang who wrote (230)10/25/1997 5:31:00 PM
From: Hong-Lee Yu   of 328
 
Steven,

Thanks for your post of playback number.
I did listen to it. Here is what I remembered.

1) Q3 results include 1M US sales of Ambisome (no royalty)
2) Expects flat or slight lower R & D (about 50 M in 1997) and flat and slightly higher S G & A (45M in 1997). 100M+ in Non-USA sales, 45-75M in USA.
3) Incomes from R & D may reach 10M in 1998.
4) 1998 will be profitable.

Hong-Lee
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News